Among the senior officials set to participate in the upcoming Biomed Israel conference are Richard Francis, president and CEO of Teva; Dr. Aharon (Roni) Gal, head of strategy and growth at Novartis; Prof. Yitzhak Kreis, director of the Sheba Medical Center; and many more. The conference is the largest meeting place for healthcare professionals in Israel, providing a platform for networking and driving business opportunities. Over 100 Israeli companies from various life sciences fields will present their solutions and technologies, offering a unique opportunity for visitors to experience innovation in the industry.
The conference will cover all areas of life sciences, including biopharma, medical devices, digital health, and diagnostic products. Attendees can expect lectures and discussions on the latest trends and breakthroughs in medicine, such as women’s health, home hospitalization, AI in drug discovery, healthy aging, and genetic medicine. Other topics to be discussed include brain health, cardiovascular diseases, digital biomarkers, medical devices, cancer treatments, and more.
Ruthie Alon, founder and CEO of Medstrada and co-chair of the conference, emphasized the importance of showcasing Israel’s contributions to the global life sciences industry. Co-chair Dr. Ora Der highlighted Israel’s innovation in medical technologies, combining technology with biology, chemistry, and medicine. The Innovation Authority has played a key role in supporting the industry’s growth, providing funding for research, start-ups, and infrastructure.
The conference aims to explore new models for disease treatment, healthcare costs, and the conversion of medical data into knowledge. Dr. Nissim Darvish, CEO of the Eliraz Ventures Fund, acknowledged the Innovation Authority’s support in driving the success of the health technology sector in Israel. The event will provide a platform for industry leaders to discuss the latest advancements and collaborations in the field.